Chapin Davis, Inc.
Source: SEC Form 13F · as of Mar 2026Chapin Davis, Inc. holds 18 biotech & pharma companies tracked by BioSniper, totaling $29.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$29.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 28,784 | $7.0M |
| MRNAModerna, Inc. | 125,539 | $6.4M |
| ABBVAbbVie Inc. | 14,263 | $3.1M |
| LLYELI LILLY & Co | 2,851 | $2.6M |
| AMGNAMGEN INC | 6,260 | $2.2M |
| MRKMerck & Co., Inc. | 14,820 | $1.8M |
| PFEPFIZER INC | 51,680 | $1.5M |
| BMYBRISTOL MYERS SQUIBB CO | 21,580 | $1.3M |
| GMOptec International, Inc. | 11,122 | $829K |
| DYAIDYADIC INTERNATIONAL INC | 888,004 | $728K |
| ABTABBOTT LABORATORIES | 4,908 | $504K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 7,988 | $441K |
| AZNASTRAZENECA PLC | 1,834 | $362K |
| PMPhilip Morris International Inc | 1,922 | $318K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 844 | $279K |
| TRVITrevi Therapeutics, Inc. | 20,100 | $240K |
| SRTSSensus Healthcare Inc. | 26,000 | $103K |
| LCTXLineage Cell Therapeutics, Inc. | 20,029 | $32K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.